Cargando…
535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection
BACKGROUND: In patients with bloodstream infections (BSI), the BioFire blood culture identification (BCID2) multiplex PCR panel is associated with decreased time to organism identification and antimicrobial susceptibility results needed to guide optimal therapy. While the performance of BCID2 has be...
Autores principales: | Palacios, Carlo Foppiano, Peaper, David, Malinis, Maricar F, Perreault, Sarah, Cohen, Elizabeth A, Vogel, Joshua, Azar, Marwan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752191/ http://dx.doi.org/10.1093/ofid/ofac492.588 |
Ejemplares similares
-
1368. The Clinical Impact of BioFire BCID2 Compared to BCID in a U.S. Pediatric Hospital
por: Graff, Kelly E, et al.
Publicado: (2020) -
Nocardiosis and elevated beta-d-glucan in solid organ transplant recipients
por: Ringer, Matthew, et al.
Publicado: (2021) -
Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
por: Radcliffe, Christopher, et al.
Publicado: (2023) -
Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies
por: Trubin, Paul A., et al.
Publicado: (2020) -
1388. Characteristics of Non-Tuberculous Mycobacterial Infections in Hematopoietic Stem-Cell Transplant Patients
por: Gleeson, Shana E, et al.
Publicado: (2019)